drug-interaction-checker

To check drug-drug interactions, evaluate active medication pairs against a known interaction reference. This process cross-checks all active medications, classifies severity, and identifies mechanisms to guide safe prescribing decisions.

CYP450 pathway analysis identifies metabolic mechanisms behind drug-drug interactions. By evaluating how active medications interact via cytochrome P450 enzymes, you can accurately classify interaction severity and predict potential adverse events.

The best way to screen new prescriptions is to evaluate the newly prescribed drug against the patient's current medications. This identifies potential interactions, reports severity, and provides targeted management recommendations.

Yes, evaluating active medications provides targeted management recommendations and alternatives for high-risk pairs. It assesses regimen safety across multiple drug classes to prevent adverse events during polypharmacy.

Yes, the drug interaction checker supports FHIR data for clinical decision support. It parses Patient demographics and medication lists formatted as FHIR resources to perform comprehensive interaction screening.

While it considers renal and hepatic function to assess risk, interaction screening relies on known reference data. Extremely rare or novel interactions may not be captured, requiring additional clinical judgment for severe organ impairment cases.